|Articles|August 9, 2021

Pharmaceutical Executive

  • Pharmaceutical Executive-08-01-2021
  • Volume 41
  • Issue 8

Pharmaceutical Executive, August 2021 Issue (PDF)

Click the title above for a link to open the Pharmaceutical Executive August 2021 issue in an interactive PDF format.

Click cover to access PDF

Articles in this issue

over 4 years ago

Why the Pandemic is Rewriting the Biopharma Rule Book

over 4 years ago

Primary Care in Crisis: PCP Navigation in a Specialty World

over 4 years ago

A Brave New World: Optimizing Access in Wake of COVID

over 4 years ago

By Any Genes Necessary: The Role of MEAs for Gene Therapies

over 4 years ago

A Framework for Future: Strengthening Market Access Competencies

over 4 years ago

Value Risk and Reward: Taking Stock of Value-Based Contracts in Pharma

over 4 years ago

Capitalizing on Collaboration: The Effort to Sustain Pandemic-Partnering Momentum

over 4 years ago

A Global Vision for Access

over 4 years ago

Early Payer-Related Lessons for Pharma Post-Aduhelm Approval

over 4 years ago

Biotech Capital Markets Continue to Underperform

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!